Alamea Verwaltungs GmbH Invests $218,000 in Axon Enterprise, Inc $AXON

Key Points

• Alamea Verwaltungs GmbH has invested $218,000 in Axon Enterprise, acquiring 415 shares of the biotechnology company's stock during the first quarter.
• Multiple hedge funds, including the Kentucky Retirement Systems Insurance Trust Fund and Quotient Wealth Partners LLC, have also recently increased their stakes in Axon Enterprise.
• Axon Enterprise reported a significant earnings surprise for the last quarter, with earnings per share of $2.12, exceeding estimates by $0.58, and revenue growth of 32.6% compared to the previous year.

Alamea Verwaltungs GmbH acquired a new position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 415 shares of the biotechnology company's stock, valued at approximately $218,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. TCTC Holdings LLC raised its stake in shares of Axon Enterprise by 75.0% during the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock worth $29,000 after purchasing an additional 24 shares in the last quarter. Fourth Dimension Wealth LLC purchased a new stake in shares of Axon Enterprise during the 4th quarter worth about $30,000. Bartlett & CO. Wealth Management LLC raised its stake in shares of Axon Enterprise by 132.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock worth $31,000 after purchasing an additional 33 shares in the last quarter. Catalyst Capital Advisors LLC purchased a new stake in shares of Axon Enterprise during the 1st quarter worth about $32,000. Finally, Alpine Bank Wealth Management purchased a new stake in shares of Axon Enterprise during the 1st quarter worth about $40,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, August 11th. The stock was sold at an average price of $831.29, for a total transaction of $8,312,900.00. Following the sale, the chief executive officer owned 3,053,982 shares of the company's stock, valued at approximately $2,538,744,696.78. This trade represents a 0.33% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Jennifer H. Mak sold 75 shares of Axon Enterprise stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $723.50, for a total value of $54,262.50. Following the sale, the chief accounting officer directly owned 15,080 shares in the company, valued at $10,910,380. The trade was a 0.49% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 34,865 shares of company stock worth $26,926,433. 5.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Needham & Company LLC set a $870.00 price objective on Axon Enterprise and gave the company a "buy" rating in a report on Tuesday, August 5th. Northland Securities set a $800.00 price objective on Axon Enterprise in a report on Tuesday, August 5th. Craig Hallum raised Axon Enterprise from a "hold" rating to a "buy" rating and set a $900.00 price objective on the stock in a report on Tuesday, August 5th. Morgan Stanley set a $885.00 price objective on Axon Enterprise and gave the company an "overweight" rating in a report on Friday, July 11th. Finally, The Goldman Sachs Group increased their price objective on Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a report on Wednesday, May 14th. Thirteen investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $837.69.

Axon Enterprise Stock Performance

NASDAQ AXON traded down $18.30 during trading on Wednesday, hitting $725.29. The company's stock had a trading volume of 635,030 shares, compared to its average volume of 672,356. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. The firm has a 50 day moving average price of $769.21 and a 200 day moving average price of $678.53. The firm has a market cap of $56.94 billion, a P/E ratio of 179.08, a price-to-earnings-growth ratio of 27.43 and a beta of 1.40. Axon Enterprise, Inc has a 52 week low of $346.71 and a 52 week high of $885.91.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, topping the consensus estimate of $1.54 by $0.58. The company had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The company's revenue for the quarter was up 32.6% on a year-over-year basis. During the same period in the previous year, the business posted $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. Equities research analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.